skip to Main Content

Women’s Venture Competition Awards Ceremony
Thursday, September 24, 2020

Join AIM-HI and our generous sponsors for a fabulous evening celebrating our 8 amazing semi-finalists and their companies at our first annual Awards Ceremony for the Women’s Venture Competition. We will begin the evening with revealing the People’s Choice for Best Pitch and move to announcing our top two finalists. The top finalist of the Women’s Venture Competition will receive an equity investment of $300,000 from the AIM-HI Accelerator Fund. These funds will serve as seed money for proof of concept and proof of value on the path to clinical trials, and eventually, to therapeutics and diagnostics that will eventually save patients’ lives.

There is still time to CAST YOUR VOTE and REGISTER to join us on Thursday, September 24, when we reveal the winner of the People’s Choice Award and celebrate 8 leading edge women scientist-entrepreneurs.

Ready to do more? AIM-HI has the resources to fund only one of the finalists. But we’d like to support both! DONATE NOW and help us raise an additional $300,000 to fund both finalists and double the impact for women scientist-entrepreneurs who are creating life-saving oncology therapies!

Awards Ceremony Run of Events

7:00    Awards Ceremony Festivities Open
7:10    Anthem Video of 8 Semi-Finalists
7:15    People’s Choice for Best Pitch Revealed
7:20    Keynote Speaker
7:30    Overview from the Judging Committee
7:45    Introduce the Semi-Finalists
7:50    Announce Top 2 Finalists

Keynote Speaker

Deepa Narayanan, MS, CCDM

Deepa Narayanan, MS, CCDM

Program Director & Team Leader, SBIR/STTR Programs at National Cancer Institute

We welcome Deepa Narayanan as our Awards Ceremony Keynote Speaker for this exciting event.

Deepa is an experienced professional with expertise in commercialization of innovative healthcare technologies and a  successful background in translation of oncology products to the clinic. Her experience includes non-dilutive funding strategies, portfolio management of oncology startups, identifying technology gaps, technology development, multi-center clinical trials, regulatory approval and market launch, as well as collaborating with key opinion leaders. With a special focus on connecting innovators with high-value funding and non-funding resources, Deepa has over 15 years of experience in academic, commercial and government sectors.

Judging Committee Chairs

Barbara Weber, M.D., Chair

Barbara Weber, M.D., Chair

President & CEO, Tango Therapeutics

Raju Kucherlapati, Ph.D., Co-Chair

Raju Kucherlapati, Ph.D., Co-Chair

Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School

Selection Committee Chairs

Pamela Garzone, Ph.D., Chair

Pamela Garzone, Ph.D., Chair

Chief Medical Officer, Calibr at Scripps Research

Webster Cavenee, Ph.D., Co-chair

Webster Cavenee, Ph.D., Co-chair

Director of Strategic Alliances, Ludwig Institute for Cancer Research

Partner Organizations

NFCR-logo

Sponsor Organizations

Microsoft
Scripps Research
Dorsey
Incutabe
GoMo Health
BLA Regulatory
NEA
SamsaraBioCapital
Back To Top